Lexicon Pharmaceuticals Inc (STU:LX31)
€ 4.096 0 (0%) Market Cap: 275.49 Mil Enterprise Value: 126.67 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 52/100

Lexicon Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 06:30PM GMT
Release Date Price: €4.1
Colin Minicus JPMorgan;Analyst

Morning, everyone. I'm Colin Minicus. I'm an associate here at JPMorgan Healthcare Group. It's my pleasure to welcome Lexicon to the 42nd Annual JP Morgan Healthcare Conference.

As just a quick reminder, we plan to hold Q&A at the end of today's session.

Now without further ado, please welcome CEO, Lonnel Coats.

Lonnel Coats Lexicon Pharmaceuticals
Inc. - CEO & Director

Thank you, Colin, and thank all of you who have made time to be here live at the conference and for all of those who are on webcast. Today, I'll be making forward-looking statements. Some of those statements certainly may have risk. I encourage you all to look at our SEC filings where our risks are contained there.

As always, I make these presentations on behalf of all the extraordinary men and women at Lexicon that work tirelessly every day to translate our mission into helping patients live better lives.

With that being said, let me move to the first slide and say for those of you who do not know much about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot